1Van der Voort OH, Gerritsen RT, Kuiper MA, et al. Filter run time in CWH:pre-versus postdilution and nadroparin versus regional heparinprotamine anticoagulation[J]. Blood, Purif, 2005, 23:175- 180.
2Stamatiadis DN, Helioti H, Mansour M,et al. Hemodialysis for patients bleeding or a risk for bleeding, can be simple, safe and efficient [J]. Clin Nephrol, 2004,62 ( 1 ) : 29-34.
3Hetzel GR, Sucker C. The heparin: all a nephrologist should know[J]. Nephrol Dial Transplant, 2005, 20:2036- 2042.
5Bihorac A, Ross EA. Continuous venovenous hemofiltration with citrate-based replacement fluid: effiCacy, safety, and impact on nutrition[J]. Am J Kidney Dis, 2005,46 (5) : 908- 918.
7Ridel C, Uereada L, Bene B, et al. Regional citrateanticoagulation during hemodialysis: a simplified proeedureusing Duocart biofiltration[J]. Blood Purif, 2005,23(6) : 473-480.
8Weijmer MC, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients[J]. J Am Soc Nephrol, 2005,16 (9) : 2769-2777.
9Hetzet GR, Taskaya G,Sucker C, et al. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration [J]. Am J Kidney Dis, 2006,48 (5): 806- 811.
10Murray PT, Reddy BV,Grossman EJ,et al. A prospective com parison of three argatroban treatment regimens during hemodialy sis in endstage renal disease[J]. Kidney Int,2004, 66(6):2446.
2Ronco C,Bellomo R.Acute renal failure and multiple organ dysfunction in the ICU:from renal replacement therapy (RRT) to multiple organ support therapy (MOST)[J].Int J Art Org,2002,25:733-747.
3Bartholomew JR,Begelman SM,Almahameed A.Heparin-induced thrombocytopenia:principles for early recognition and management[J].Cleve Clin J Med,2005,72 (1):31 -36.
4Rempher KJ.Continuous renal replacement therapy for management of overhydration in heart failure[J].AACN Clin Issues,2003,14 (4):512-519.
5Uchino S,Fealy N,Baldwin I,et al.Continuous venovenous hemofiltration without anticoagulation[J].ASAIO J,2004,50(1):76-80.
6van de Wetering J, Westendorp RG, van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorr- hage. J Am Soc Nephrol, 1996, 7:145-150.
7Swartz R, Pasko D, O' Toole J, et al. Improving the delivery of continuous renal replacement therapy using region- al citrate anticoagulation. Clin Nephrol, 2004,61 : 134-143.
